Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Novabay Pharmaceuticals (NBY)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,926
  • Shares Outstanding, K 17,090
  • Annual Sales, $ 18,230 K
  • Annual Income, $ -7,400 K
  • 36-Month Beta -1.12
  • Price/Sales 1.31
  • Price/Cash Flow N/A
  • Price/Book 3.22

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 2 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/18
See More
  • Average Estimate -0.09
  • Number of Estimates 2
  • High Estimate -0.08
  • Low Estimate -0.10
  • Prior Year -0.16
  • Growth Rate Est. (year over year) +43.75%

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.25 +60.00%
on 09/10/18
2.05 -2.44%
on 08/24/18
+0.05 (+2.56%)
since 08/21/18
3-Month
1.25 +60.00%
on 09/10/18
2.64 -24.24%
on 06/25/18
-0.60 (-23.08%)
since 06/21/18
52-Week
1.25 +60.00%
on 09/10/18
4.80 -58.33%
on 10/27/17
-2.50 (-55.56%)
since 09/21/17

Most Recent Stories

More News
NovaBay Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / August 7, 2018 / NovaBay Pharmaceuticals, Inc. (NYSE MKT: ) will be discussing their earnings results in their Q2 Earnings Call to be held on August 7, 2018 at 4:30 PM Eastern...

NBY : 2.00 (+42.86%)
NovaBay Pharmaceuticals, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / March 20, 2018 / NovaBay Pharmaceuticals, Inc. (NYSE American: NBY) will be discussing their earnings results in their Q4 Earnings Call to be held on March 20, 2018, at 4:30...

NBY : 2.00 (+42.86%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 16% Buy with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Trade NBY with:

Business Summary

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing innovative product candidates targeting the treatment or prevention of a wide range of infections in hospital and non-hospital environments. NovaBay has discovered and is developing a class of antimicrobial compounds,...

See More

Key Turning Points

2nd Resistance Point 2.43
1st Resistance Point 2.22
Last Price 2.00
1st Support Level 1.57
2nd Support Level 1.13

See More

52-Week High 4.80
Fibonacci 61.8% 3.44
Fibonacci 50% 3.03
Fibonacci 38.2% 2.61
Last Price 2.00
52-Week Low 1.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar